Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

The cost of childhood epilepsy in Croatia (CROSBI ID 490534)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | domaća recenzija

Prpić, Igor ; Paučić-Kirinčić, Ela ; Fiket, Daniela ; Vukmir-Turković, Biljana The cost of childhood epilepsy in Croatia // Paediatria Croatica / Barišić, Ingeborg (ur.). Zagreb: Klinika za dječje bolesti, 2003. str. 127-x

Podaci o odgovornosti

Prpić, Igor ; Paučić-Kirinčić, Ela ; Fiket, Daniela ; Vukmir-Turković, Biljana

engleski

The cost of childhood epilepsy in Croatia

In Croatia there are no exact data about cost of any chronic disease and thus non for epilepsy. Moreover, attention about cost-benefit ratio and treatment algorithms for most disease is just in process of development. For these reason, we calculated the cost of newly diagnosed epilepsy during the first year of disease. We included in the study all children and adolescents in whom epilepsy was first diagnosed (ILAE classification) at the Department of Pediatrics &laquo ; ; Kantrida&raquo ; ; , at the University Hospital Centre Rijeka, Croatia in the year 1999. The cost was recorded retrospectively for each patient of hospital admission days (included cost of preformed laboratory tests, EEG recording, neuro-radiological examinations, medical consultations, and child psychologist evaluation), antiepileptic treatment and outpatients visits throughout first year of the disease. The cost of epilepsy was calculated by multiplying each resource used (days in hospital, tests, consultations, treatment) by its units cost. Unit cost is defined as the standard Croatian Health care Administration accepted values for each hospital day or diagnostic procedure, expressed in Euros. The estimated cost of epilepsy is 872, 19 Euros per patient per year, of which 74, 6% is the cost of hospital admission, 15.5% of treatment and 9.9% of outpatient’ s visits. We presume that with better organization of the hospital admission cost could be rationalized. Other possibilities for cost reduction are appropriate antiepileptic drugs treatment using valproate as the fist line drug for generalized seizure and as the first drug among the second line drugs for partial seizure. The new generation of AED, which are ore expensive, should be reserved for resistant epilepsy and children who developed side effects while on standard antiepileptic drugs. Regarding the common clinical practice in Croatia, the study results can be considered valuable for the entire county. To the best of our knowledge this is the first study of this nature in Croatia.

epilepsy; cost; children

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

127-x.

2003.

objavljeno

Podaci o matičnoj publikaciji

Paediatria Croatica

Barišić, Ingeborg

Zagreb: Klinika za dječje bolesti

Podaci o skupu

9th MEDITERRANEAN MEETING OF CHILD NEUROLOGY

pozvano predavanje

29.05.2003-31.05.2003

Dubrovnik, Hrvatska

Povezanost rada

Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita